Arcturus Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CVAC | F | CureVac N.V. | -1.62 | |
TAK | F | Takeda Pharmaceutical Company Limited | -0.38 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PPH | B | Market Vectors Pharmaceutical ETF | 4.03 | |
GERM | B | ETFMG Treatments Testing and Advancements ETF | 2.32 | |
FLCO | C | Franklin Liberty Investment Grade Corporate ETF | 1.02 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.47 | |
WDNA | D | WisdomTree BioRevolution Fund | 0.36 |
Compare ETFs
- Arcturus Therapeutics
Arcturus Therapeutics is an American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA. Arcturus has developed a novel, potent and safe RNA therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, gene editing, DNA, antisense, and microRNA oligotherapeutics.
The company's pipeline includes RNA therapeutics towards rare diseases such as ornithine transcarbamylase deficiency (OTCD), and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19, currently co-developed with Singaporean scientists at Duke–NUS Medical School.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles